Australia -
English -
Department of Health (Therapeutic Goods Administration)
defitelio defibrotide 200 mg/2.5 ml concentrated solution for infusion vial
jazz pharmaceuticals anz pty ltd - defibrotide, quantity: 200 mg - injection, concentrated - excipient ingredients: hydrochloric acid; sodium citrate dihydrate; sodium hydroxide; water for injections - defitelio is indicated for the treatment of severe hepatic veno-occlusive disease (vod) also known as sinusoidal obstruction syndrome (sos) in haematopoietic stem-cell transplantation (hsct) therapy.,it is indicated in adults and in adolescents, children and infants of 1 month of age and above.